Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice
Shigeki Nakamura, Kimberly M. Davis, Jeffrey N. Weiser
Shigeki Nakamura, Kimberly M. Davis, Jeffrey N. Weiser
View: Text | PDF
Research Article

Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice

  • Text
  • PDF
Abstract

Pneumococcal infection of the respiratory tract is often secondary to recent influenza virus infection and accounts for much of the morbidity and mortality during seasonal and pandemic influenza. Here, we show that coinfection of the upper respiratory tract of mice with influenza virus and pneumococcus leads to synergistic stimulation of type I IFNs and that this impairs the recruitment of macrophages, which are required for pneumococcal clearance, due to decreased production of the chemokine CCL2. Type I IFN expression was induced by pneumococcal colonization alone. Colonization followed by influenza coinfection led to a synergistic type I IFN response, resulting in increased density of colonizing bacteria and susceptibility to invasive infection. This enhanced type I IFN response inhibited production of the chemokine CCL2, which promotes the recruitment of macrophages and bacterial clearance. Stimulation of CCL2 by macrophages upon pneumococcal infection alone required the pattern recognition receptor Nod2 and expression of the pore-forming toxin pneumolysin. Indeed, the increased colonization associated with concurrent influenza virus infection was not observed in mice lacking Nod2 or the type I IFN receptor, or in mice challenged with pneumococci lacking pneumolysin. We therefore propose that the synergistic stimulation of type I IFN production during concurrent influenza virus and pneumococcal infection leads to increased bacterial colonization and suggest that this may contribute to the higher rates of disease associated with coinfection in humans.

Authors

Shigeki Nakamura, Kimberly M. Davis, Jeffrey N. Weiser

×

Figure 5

Macrophages and Nod2 contribute to production of type I IFN by S. pneumoniae.

Options: View larger image (or click on image) Download as PowerPoint
Macrophages and Nod2 contribute to production of type I IFN by S. pneumo...
(A) The levels of type I IFN mRNA in URT lavages of WT and Ccr2–/– mice were analyzed 7 days after intranasal infection with strain P1121 by qRT-PCR. (B) The levels of type I IFN mRNA in URT lavages of WT (black bars) and Tlr2–/– (white bars) mice were analyzed 3 days after intranasal infection with strain P1121. (C) The levels of IFN-β mRNA in URT lavages of WT (black bars) and Nod2–/– (white bars) mice were analyzed 3 days after intranasal infection with strain P1121. Levels of IFN-β mRNA in peritoneal macrophages from WT and Nod2–/– mice were examined 12 hours after stimulation with heat-killed strain P1121. Levels of (D) IFN-β and (E) Ccl2 mRNA in URT lavages of singly infected and coinfected Nod2–/– mice determined by qRT-PCR. (F) Density of pneumococcal colonization in URT lavages of singly infected and coinfected Nod2–/– mice day 7 after challenge with influenza virus PR8. Horizontal lines indicate mean values. (G) The levels of type I IFN mRNA in bone marrow–derived macrophages from WT, Irf3–/–, Irf5–/–, Irf3–/–Irf5–/– mice were examined 12 hours after stimulation with heat-killed strain P1121. Values represent mean ± SD. *P < 0.05, **P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts